Page last updated: 2024-08-24

imiquimod and Cancer of Head

imiquimod has been researched along with Cancer of Head in 23 studies

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (39.13)	29.6817
2010's	14 (60.87)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balasis, S; Georgiou, S; Koumoundourou, D; Mallioris, AF; Plachouri, KM	1
Brand, FL; Hunger, RE; Seyed Jafari, SM	1
Hsia, HC; Kim, S; Narayan, D; Norwich-Cavanaugh, A; Tsay, C	1
Argenziano, G; Drummond, A; Lallas, A; Longo, C; Moscarella, E; Piana, S; Pichler, J; Zalaudek, I	1
Ahmad, K; Alani, A; Ramsay, B	1
de Vries, K; Greveling, K; Prens, EP; van Doorn, MB	1
Bartha, Á; Dirschka, T; Schmitz, L	1
Grady, BE; Spencer, JM	1
Harth, W; Heber, G; Helbig, D; Pönitzsch, I; Simon, JC; Wetzig, T	1
Dengel, LT; Grosh, WW; Harris, RC; Patterson, JW; Slingluff, CL; Turza, K; White, K	1
Bonnekoh, B; Fehsecke, D; Franke, I; Froster, UG; Gollnick, HP; Helmdach, M; Kraus, C; Quist, SR; Reis, A	1
Apalla, Z; Ioannides, D; Lallas, A; Sotiriou, E	1
McLaughlin, PJ; Stucki, JK; Zagon, IS	1
Guillén, C; Hilari, H; Llombart, B; Llorca, D; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V; Villanueva, A	1
Urbina, F	1
Armario-Hita, J; Fernández-Vozmediano, J	1
Casado, M; González-Beato, M; Mayor, M; Miralles, L; Pizarro, A; Sigüenza, M; Vidaurrázaga, C	1
Bogeschdorfer, F; Gronau, S; Riechelmann, H	1
Goh, MS	1
Ho, NT; Lansang, P; Pope, E	1
Bunker, CB; Singh, S	1
Bystryn, JC; Czernik, A	1
Donahue, RN; McLaughlin, PJ; Rogosnitzky, M; Zagon, IS	1

Reviews

2 review(s) available for imiquimod and Cancer of Head

Article	Year
[Topical treatment of melanoma skin metastases with imiquimod]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Scalp; Skin Neoplasms	2005
[New substances in the therapy of head and neck cancer]. Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7 Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration	2006

Article

Year

[Topical treatment of melanoma skin metastases with imiquimod].

Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:2

Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Scalp; Skin Neoplasms

2005

[New substances in the therapy of head and neck cancer].

Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7

Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration

2006

Other Studies

21 other study(ies) available for imiquimod and Cancer of Head

Article	Year
Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream. Dermatologic therapy, 2018, Volume: 31, Issue:5 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasms, Multiple Primary; Scalp; Skin Cream; Skin Neoplasms	2018
Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy. Dermatology (Basel, Switzerland), 2019, Volume: 235, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Contraindications, Procedure; Dermatologic Surgical Procedures; Dermoscopy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome	2019
An Algorithm for the Management of Residual Head and Neck Melanoma In Situ Using Topical Imiquimod: A Pilot Study. Annals of plastic surgery, 2019, Volume: 82, Issue:4S Suppl 3 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Female; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm, Residual; Pilot Projects; Retrospective Studies; Skin Neoplasms	2019
Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome. The Australasian journal of dermatology, 2015, Volume: 56, Issue:4 Topics: Alopecia; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Drug Eruptions; Female; Head and Neck Neoplasms; Humans; Imiquimod; Lichen Planus; Middle Aged; Scalp; Skin Cream; Skin Neoplasms	2015
Diagnosis of Amelanotic Lentigo Maligna by Using In vivo Reflectance Confocal Microscopy. Acta dermato-venereologica, 2016, Volume: 96, Issue:3 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cell Proliferation; Epidermis; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanocytes; Melanoma, Amelanotic; Microscopy, Confocal; Predictive Value of Tests; Skin Neoplasms; Treatment Outcome	2016
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose. The British journal of dermatology, 2016, Volume: 174, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Leg; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Treatment Outcome	2016
Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report. European journal of dermatology : EJD, 2016, Aug-01, Volume: 26, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasm Invasiveness; Scalp; Skin Neoplasms	2016
Topical imiquimod clears invasive melanoma. Cutis, 2016, Volume: 98, Issue:5 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Scalp; Skin Neoplasms	2016
Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2009, Volume: 7, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Middle Aged; Remission Induction; Scalp; Skin Neoplasms; Treatment Outcome	2009
Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis. Journal of cutaneous pathology, 2010, Volume: 37, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Dermis; Female; Head and Neck Neoplasms; Humans; Imiquimod; Melanoma; Middle Aged; Skin Neoplasms; Subcutaneous Tissue; Treatment Outcome	2010
Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer. Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:3 Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Imiquimod; Middle Aged; Patched Receptors; Receptors, Cell Surface; Scalp; Skin Neoplasms	2011
Treatment of giant Bowen's disease with sequential use of photodynamic therapy and imiquimod cream. Photodermatology, photoimmunology & photomedicine, 2011, Volume: 27, Issue:3 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Head and Neck Neoplasms; Humans; Imiquimod; Male; Photochemotherapy; Remission Induction; Skin Neoplasms	2011
Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck. Head & neck, 2012, Volume: 34, Issue:4 Topics: Aminoquinolines; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Imiquimod; Injections, Intraperitoneal; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Receptors, Opioid; Reference Values; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous; Treatment Outcome; Tumor Burden; Up-Regulation	2012
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:7 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Paraffin Embedding; Reoperation; Retrospective Studies; Skin Neoplasms; Skin Pigmentation; Treatment Outcome	2012
Giant basal cell carcinoma. Improvement and vitiligo-like hypopigmentation after intermittent treatment with 5% imiquimod. Acta dermatovenerologica Croatica : ADC, 2012, Volume: 20, Issue:4 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Head and Neck Neoplasms; Humans; Imiquimod; Scalp; Skin Neoplasms; Vitiligo	2012
Infiltrative squamous cell carcinoma on the scalp after treatment with 5% imiquimod cream. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:4 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Squamous Cell; Dosage Forms; Head and Neck Neoplasms; Humans; Imiquimod; Male; Scalp; Skin Neoplasms	2005
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream. The Australasian journal of dermatology, 2006, Volume: 47, Issue:3 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Head and Neck Neoplasms; Humans; Imiquimod; Leg; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Scalp; Skin Neoplasms; Treatment Outcome	2006
Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Child, Preschool; Drug Eruptions; Facial Neoplasms; Female; Head and Neck Neoplasms; Hemangioma; Humans; Imiquimod; Infant; Infant, Newborn; Interferon Inducers; Male; Ointments; Remission Induction; Retrospective Studies; Severity of Illness Index; Skin Neoplasms; Treatment Outcome	2007
Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream. Clinical and experimental dermatology, 2007, Volume: 32, Issue:5 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Keratosis; Male; Radiodermatitis; Scalp; Skin Neoplasms	2007
Does imiquimod work in infantile hemangiomas? Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Head and Neck Neoplasms; Hemangioma; Humans; Imiquimod; Infant; Infant, Newborn	2007
Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function. Experimental biology and medicine (Maywood, N.J.), 2008, Volume: 233, Issue:8 Topics: Adenocarcinoma; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Head and Neck Neoplasms; Humans; Imiquimod; Immunity; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; RNA, Small Interfering; Up-Regulation	2008